Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in patients with glaucoma and NAION.
The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients ...
BOSTON, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Life Biosciences, Inc., (“Life Bio”) a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, ...
Epigenomics is at the forefront of biomedical innovation, offering unprecedented insights into the mechanisms that regulate ...
Metabolic diseases such as obesity, fatty liver, and insulin resistance are rapidly increasing worldwide, but fundamental ...
A newly discovered biological signal in the blood could help health care teams and researchers better understand how children respond to brain injuries at the cellular level, according to our research ...
The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients ...
Image Caption: Epigenetic regulation of receptors. Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of ...
Researchers at Monash University and Peter MacCallum Cancer Centre have identified for the first time how a new class of epigenetic drug engages with the immune system to kill off cancer cells, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results